• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在MHC I类分子进行抗原呈递之前,肽在细胞核和细胞质区室中的扩散、保护及降解。

Peptide diffusion, protection, and degradation in nuclear and cytoplasmic compartments before antigen presentation by MHC class I.

作者信息

Reits Eric, Griekspoor Alexander, Neijssen Joost, Groothuis Tom, Jalink Kees, van Veelen Peter, Janssen Hans, Calafat Jero, Drijfhout Jan Wouter, Neefjes Jacques

机构信息

Department of Tumor Biology and Cell Biology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.

出版信息

Immunity. 2003 Jan;18(1):97-108. doi: 10.1016/s1074-7613(02)00511-3.

DOI:10.1016/s1074-7613(02)00511-3
PMID:12530979
Abstract

Antigenic peptides generated by the proteasome have to survive a peptidase-containing environment for presentation by MHC class I molecules. We have visualized the fate and dynamics of intracellular peptides in living cells. We show that peptides are distributed over two different but interconnected compartments, the cytoplasm and the nucleus, and diffuse rapidly through and between these compartments. Since TAP is excluded from the nuclear face of the nuclear envelope, nuclear peptides have to leave the nucleus to contact TAP. Thereby, these peptides encounter cytosolic peptidases that degrade peptides within seconds unless bound to chromatin. Since peptide degradation is far more efficient than translocation, many peptides will be lost for antigen presentation by MHC class I molecules.

摘要

蛋白酶体产生的抗原肽必须在含有肽酶的环境中存活下来,以便由MHC I类分子进行呈递。我们已经观察到活细胞内肽的命运和动态。我们发现,肽分布在两个不同但相互连接的区室,即细胞质和细胞核中,并在这些区室之间快速扩散。由于转运体相关蛋白(TAP)被排除在核膜的核面之外,核内肽必须离开细胞核才能与TAP接触。因此,这些肽会遇到胞质肽酶,除非与染色质结合,否则这些肽酶会在几秒钟内降解肽。由于肽的降解比转运效率高得多,许多肽将无法用于MHC I类分子的抗原呈递。

相似文献

1
Peptide diffusion, protection, and degradation in nuclear and cytoplasmic compartments before antigen presentation by MHC class I.在MHC I类分子进行抗原呈递之前,肽在细胞核和细胞质区室中的扩散、保护及降解。
Immunity. 2003 Jan;18(1):97-108. doi: 10.1016/s1074-7613(02)00511-3.
2
Proteolysis and class I major histocompatibility complex antigen presentation.蛋白水解作用与I类主要组织相容性复合体抗原呈递
Immunol Rev. 1999 Dec;172:49-66. doi: 10.1111/j.1600-065x.1999.tb01355.x.
3
The cytosolic endopeptidase, thimet oligopeptidase, destroys antigenic peptides and limits the extent of MHC class I antigen presentation.胞质内肽酶,硫醚寡肽酶,可破坏抗原肽并限制MHC I类抗原呈递的程度。
Immunity. 2003 Mar;18(3):429-40. doi: 10.1016/s1074-7613(03)00058-x.
4
Processing and delivery of peptides presented by MHC class I molecules.MHC I类分子呈递的肽段的加工与递呈
Curr Opin Immunol. 1996 Feb;8(1):59-67. doi: 10.1016/s0952-7915(96)80106-3.
5
Degradation of cell proteins and the generation of MHC class I-presented peptides.细胞蛋白质的降解与MHC I类呈递肽的产生。
Annu Rev Immunol. 1999;17:739-79. doi: 10.1146/annurev.immunol.17.1.739.
6
Generation, translocation, and presentation of MHC class I-restricted peptides.MHC I类限制性肽的产生、转运及呈递。
Annu Rev Biochem. 1995;64:463-91. doi: 10.1146/annurev.bi.64.070195.002335.
7
Beyond the proteasome: trimming, degradation and generation of MHC class I ligands by auxiliary proteases.蛋白酶体之外:辅助蛋白酶对MHC I类配体的修剪、降解及生成
Mol Immunol. 2002 Oct;39(3-4):203-15. doi: 10.1016/s0161-5890(02)00102-5.
8
Generating MHC class I ligands from viral gene products.从病毒基因产物生成MHC I类配体。
Immunol Rev. 1999 Dec;172:97-108. doi: 10.1111/j.1600-065x.1999.tb01359.x.
9
Functional regulation of immunoproteasomes and transporter associated with antigen processing.免疫蛋白酶体及抗原加工相关转运体的功能调控
Immunol Res. 2001;24(3):245-72. doi: 10.1385/IR:24:3:245.
10
Assembly and intracellular transport of MHC class I and class II molecules.主要组织相容性复合体I类和II类分子的组装与细胞内运输。
Cold Spring Harb Symp Quant Biol. 1995;60:249-61. doi: 10.1101/sqb.1995.060.01.029.

引用本文的文献

1
Multifactorial Remodeling of the Cancer Immunopeptidome by IFNγ.干扰素 γ 对癌症免疫肽组学的多因素重塑。
Cancer Res Commun. 2023 Nov 17;3(11):2345-2357. doi: 10.1158/2767-9764.CRC-23-0121.
2
mRNA-based Vaccines Targeting the T-cell Epitope-rich Domain of Epstein Barr Virus Latent Proteins Elicit Robust Anti-Tumor Immunity in Mice.基于 mRNA 的疫苗针对 Epstein Barr 病毒潜伏蛋白的 T 细胞表位丰富域,在小鼠中引发了强大的抗肿瘤免疫。
Adv Sci (Weinh). 2023 Dec;10(35):e2302116. doi: 10.1002/advs.202302116. Epub 2023 Oct 27.
3
De-risking clinical trial failure through mechanistic simulation.
通过机制模拟降低临床试验失败的风险。
Immunother Adv. 2022 Aug 23;2(1):ltac017. doi: 10.1093/immadv/ltac017. eCollection 2022.
4
Bioinspired vaccines to enhance MHC class-I antigen cross-presentation.仿生疫苗增强 MHC Ⅰ类抗原交叉呈递。
Curr Opin Immunol. 2022 Aug;77:102215. doi: 10.1016/j.coi.2022.102215. Epub 2022 Jun 4.
5
Cryo-EM structure of the plant 26S proteasome.植物 26S 蛋白酶体的冷冻电镜结构。
Plant Commun. 2022 May 9;3(3):100310. doi: 10.1016/j.xplc.2022.100310. Epub 2022 Mar 11.
6
Effect of FKBP12-Derived Intracellular Peptides on Rapamycin-Induced FKBP-FRB Interaction and Autophagy.FKBP12 衍生细胞内肽对雷帕霉素诱导的 FKBP-FRB 相互作用和自噬的影响。
Cells. 2022 Jan 24;11(3):385. doi: 10.3390/cells11030385.
7
Peptidome: Chaos or Inevitability.肽组学:混沌还是必然。
Int J Mol Sci. 2021 Dec 4;22(23):13128. doi: 10.3390/ijms222313128.
8
Chemically Tuning the Antigen Release Kinetics from Spherical Nucleic Acids Maximizes Immune Stimulation.通过化学方法调节球形核酸的抗原释放动力学可使免疫刺激最大化。
ACS Cent Sci. 2021 Nov 24;7(11):1838-1846. doi: 10.1021/acscentsci.1c00779. Epub 2021 Oct 21.
9
Challenges of Neoantigen Targeting in Lynch Syndrome and Constitutional Mismatch Repair Deficiency Syndrome.林奇综合征和遗传性错配修复缺陷综合征中新抗原靶向治疗的挑战
Cancers (Basel). 2021 May 13;13(10):2345. doi: 10.3390/cancers13102345.
10
HLA Class II Presentation Is Specifically Altered at Elevated Temperatures in the B-Lymphoblastic Cell Line JY.在 B 淋巴细胞白血病细胞系 JY 中,HLA Ⅱ类分子呈递在高温下特异性改变。
Mol Cell Proteomics. 2021;20:100089. doi: 10.1016/j.mcpro.2021.100089. Epub 2021 Apr 29.